Skip to main content
See every side of every news story
Published loading...Updated

Polycystic Ovary Syndrome Officially Renamed After 14-Year Study

The new term reflects the disorder’s hormonal and metabolic effects, and experts say up to 70% of people remain undiagnosed.

  • On Tuesday, medical experts announced Polycystic Ovary Syndrome is officially renamed Polyendocrine Metabolic Ovarian Syndrome , concluding a 14-year global consensus process involving thousands of stakeholders worldwide.
  • The previous name misleadingly focused on 'cysts' when patients actually have 'arrested follicles,' contributing to missed diagnoses because PMOS impacts metabolic and hormonal systems beyond the ovaries.
  • Professor Helena Teede at Monash University led the effort involving 56 organizations and about 22,000 global participants, aiming to improve scientific accuracy and reduce stigma linked to fertility.
  • Lorna Berry, an Australian woman with PMOS who helped lead the renaming, called the shift "accountability and progress," saying it will improve care for future generations of women.
  • Affecting 1 in 8 women, the condition remains largely undiagnosed; the team plans to integrate the new name into clinical practice over the next three years to ensure equitable healthcare.
Insights by Ground AI

106 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 59% of the sources are Center
59% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Krem2 News broke the news in Spokane, United States on Tuesday, May 12, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal